Radicle Science will launch history’s first large-scale, blinded, placebo-controlled clinical trials on rare cannabinoids including THCV, CBN, CBG, and CBC.

We’ll study their effects on energy, focus, appetite, sleep disturbance, pain, stress, and anxiety. These unprecedented Radicle Discovery studies require more than 10,000 participants and are set to kick off in early 2022.

You can read more details about these studies in our February Press Release.

Radicle Science is enrolling brands & participants for studies beginning in early 2022!

If your brand is interested in learning more about these studies at Radicle Science please book a complimentary strategy session.

If you are a consumer interested in volunteering to participate in these studies with Radicle Science, please sign up!